» Authors » Dirce Maria Carraro

Dirce Maria Carraro

Explore the profile of Dirce Maria Carraro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 115
Citations 1332
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Alves de Castro J, Kulikowski L, Wolff B, Natalino R, Carraro D, Torrezan G, et al.
Neuropathology . 2023 Oct; 44(2):167-172. PMID: 37855183
Ependymomas (EPN) are central nervous system neoplasms that exhibit an ependymal phenotype. In particular, supratentorial EPN (ST-EPN) must be differentiated from more aggressive entities such as glioblastoma, IDH-wildtype. This task...
12.
Torres J, Brito A, E Silva V, Messias I, Braun A, Ruano A, et al.
Int J Mol Sci . 2023 Aug; 24(15). PMID: 37569332
Objectives: To isolate, quantify and analyze CTCs/CTMs from metastatic NSCLC patients, identify TGFβRI/CD47 expression in CTCs/CTMs, and correlate with progression-free survival (PFS). Methods: Blood (10 mL) was collected at two...
13.
Carvalho N, Santiago K, Maia J, DAlmeida Costa F, Formiga M, de Queiroz Soares D, et al.
J Med Genet . 2023 Aug; 61(1):61-68. PMID: 37536918
Background: Sarcomas are a rare and diverse group of cancers occurring mainly in young individuals for which an underlying germline genetic cause remains unclear in most cases. Methods: Germline DNA...
14.
Moreno M, Oliveira J, Brianese R, Guedes de Castro D, Sanches S, Torrezan G, et al.
Cancer Med . 2023 Jul; 12(15):16129-16141. PMID: 37485802
Background: Triple-negative breast cancer (TNBC) is the neoplasia most associated with BRCA1 germline pathogenic variants (PV) and is more likely to develop metastases than the other breast cancer (BC) subtypes,...
15.
Dominguez-Valentin M, Haupt S, Seppala T, Sampson J, Sunde L, Bernstein I, et al.
EClinicalMedicine . 2023 May; 58:101909. PMID: 37181409
Background: The Prospective Lynch Syndrome Database (PLSD) collates information on carriers of pathogenic or likely pathogenic MMR variants () who are receiving medical follow-up, including colonoscopy surveillance, which aims to...
16.
Riechelmann R, Donadio M, de Jesus V, Carvalho N, Santiago K, Barros M, et al.
Endocr Relat Cancer . 2023 Mar; 30(6). PMID: 36947458
Neuroendocrine neoplasms (NENs) are a rare group of cancers with heterogeneous behaviour and mostly of unknown aetiology. Excluding some infrequent hereditary cancer syndromes, the extent and clinical significance of mutations...
17.
da Silva S, Alves Domingos T, Kupper B, De Brot L, Junior S, Carraro D, et al.
Exp Mol Pathol . 2023 Feb; 130:104855. PMID: 36736685
Detecting MLH1 promoter methylation is highly relevant to differentiate between possible Lynch syndrome patients or patients with sporadic causes of MLH1/PMS2 deficiency in colorectal (CRC) and endometrial cancers. Here, we...
18.
Tasic L, Avramovic N, Jadranin M, Quintero M, Stanisic D, Martins L, et al.
Biomedicines . 2022 Dec; 10(12). PMID: 36551847
Cancer is one of the leading causes of death in children and adolescents worldwide; among the types of liver cancer, hepatoblastoma (HBL) is the most common in childhood. Although it...
19.
Corassa M, Abreu R, Cordeiro de Lima V, Torrezan G, Cavalher F, Silva T, et al.
JCO Precis Oncol . 2022 Oct; 6:e2200367. PMID: 36201715
No abstract available.
20.
Moller P, Seppala T, Dowty J, Haupt S, Dominguez-Valentin M, Sunde L, et al.
Hered Cancer Clin Pract . 2022 Oct; 20(1):36. PMID: 36182917
Objective: To compare colorectal cancer (CRC) incidences in carriers of pathogenic variants of the MMR genes in the PLSD and IMRC cohorts, of which only the former included mandatory colonoscopy...